A new cystatin C based model for predicting COVID-19- associated mortality

Sümeyra KOYUNCU, Serhat KOYUNCU, Halil İbrahim AKDOĞAN, Mehmet KARA, Göksel GÜVEN, Didem BARLAK KETİ, Hilal SİPAHİOĞLU, Gözde ERTÜRK ZARARSIZ, İsmail KOÇYİĞİT, Bülent TOKGÖZ

Abstract

Background: This study aimed to investigate the effect of the Cystatin C based model on kidney function and the value of this model on predicting mortality in patients with the recent novel coronavirus disease (COVID-19).Methods: Demographic characteristics, clinical manifestations, and laboratory measurements were measured in critically ill patients with COVID-19 infection. Patients were monitored until they were discharged from the hospital or died.Results: 105 patients participated in this study. 29 of 105 patients were treated in the intensive care unit. Acute kidney injury developed in nearly all of these patients and developed in 6 other non-intensive care unit patients. 21 of the patients in the intensive care unit had exitus.Conclusion: The cystatin C (sCys C )based model may be used to predict mortality in severe COVID-19 infections.